President Donald Trump has signed a new executive order to lower prescription drug prices in the U.S. The plan would force drug companies to give Americans the same discounted prices they provide in other countries If companies fail to comply, the government could authorize more drug imports or revoke approval for certain medications. Officials have 30 days to propose pricing benchmarks.
The order revives Trump’s earlier “Most Favored Nation” policy, which was blocked in court during his first term. The updated version expands the scope to include both Medicare and the private insurance market. Trump also warned that nations pushing for low drug prices may face higher tariffs on other goods.
Experts caution that the order may not yield immediate results and could face legal obstacles. Some view it as a bold policy shift, while others see it as largely symbolic or politically motivated. With U.S. drug prices still among the highest globally, it remains uncertain whether the executive order will result in meaningful savings for patients.
SOURCE: